Clinical Trials Directory

Trials / Unknown

UnknownNCT04781179

Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia

Randomized, Controlled Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Schizophrenia is a mental pathology that concerns 1% of the French population, characterized by heterogeneity of symptoms. One of them, apathy is defined as a multidimensional psychopathological state manifested by a decrease in motivation. This deficit is most common in schizophrenia and impacts the functional outcome of patients. To date, no treatment has shown a significant effect on this symptom. In other pathologies with a motivational deficit, the technique of Mental Contrasting and Implementation Intention (CM-II) showed interesting effects in improving motivation, reducing the effort related to the action. The investigators aim to propose the CM-II technique to individuals with schizophrenia to improve apathy. The investigators expected that the CM-II technique will allow an improvement of apathy which will have beneficial effects on other psychological factors (e.g., depressive symptoms). In addition, the implementation of the CM-II will provide help to global management.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCM-IIIt is an intervention of 4 two-hour sessions with a psychologist, MC-II technique
BEHAVIORALPsychoeducationIt is an intervention of 4 two-hour sessions with a psychologist, psychoeducation

Timeline

Start date
2022-02-22
Primary completion
2023-09-01
Completion
2023-09-01
First posted
2021-03-04
Last updated
2022-03-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04781179. Inclusion in this directory is not an endorsement.